FTC Chair Lina Khan (Michael Brochstein/Sipa USA)(Sipa via AP Images)
September 20, 2024 12:00 PM EDTUpdated 02:35 PM
Pharma
Law

FTC to sue ma­jor PBMs over in­sulin re­bates, claim­ing they in­flat­ed pa­tient cost

Drew Armstrong

Executive Editor

The Fed­er­al Trade Com­mis­sion said that it is su­ing the three ma­jor US phar­ma­cy ben­e­fit man­agers over their role in the in­sulin mar­ket, claim­ing that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times